Blog

CAR T cells can gain new vigor when engineered to have high levels of a particular protein – Cancer Research Institute

Photo from Cancer Research Institute/LinkedIn

Apr 16, 2024, 01:02

CAR T cells can gain new vigor when engineered to have high levels of a particular protein – Cancer Research Institute

Cancer Research Institute posted on LinkedIn:

“Bioengineered immune cells have been shown to attack and even cure cancer, but often become exhausted over time. Researchers including former CRI Fellow Dr. Junyun Lai of Peter MacCallum Cancer Centre have now demonstrated that CAR T cells can gain new vigor when engineered to have high levels of a particular protein. These boosted CAR T cells have gene activity similar to that of stem cells, and a rejuvenated ability to fend off cancer.
Learn more.”

Source: Cancer Research Institute/LinkedIn

Bioengineered immune cells cancer Cancer Research Institute CAR-T cells cure cancer gene activity Junyun Lai OncoDaily Oncology particular protein Peter MacCallum Cancer Centre rejuvenated ability stem cells

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology